Isomex Xl (Isosorbide Mononitrate)

Isosorbide mononitrate is a prodrug that releases nitric oxide after oral absorption. Nitric oxide stimulates guanylate cyclase, raising cyclic GMP in vascular smooth muscle, causing arterial and venous dilation. This lowers preload and afterload, improving oxygen delivery to the heart.

The specific dose of Isomex Xl is determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments may be needed for renal function or concomitant medications, and the prescriber will provide individualized instructions.

Safety data for isosorbide mononitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Isomex Xl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isomex Xl belongs to the nitrate class, offering long‑acting vasodilation. Compared with short‑acting nitrates, it provides more stable plasma levels and fewer dosing fluctuations. Unlike beta‑blockers, it primarily reduces preload rather than heart rate, making it a complementary option in many treatment regimens.

Isomex Xl should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability throughout its shelf life.

Isomex Xl is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed, unless otherwise directed by a healthcare professional.

Serious risks include severe hypotension, syncope, life‑threatening arrhythmias, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, chest pain, or signs of a severe allergic response.

Isomex Xl is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or any nitrate, those who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, and individuals with severe hypotension or uncompensated heart failure unless directed by a physician.